Form 4 for EDIT Editas Medicine, Inc.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-09 · accession 0001415889-22-008463 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | 2022-08-09 | EDIT | Eaton Bruce | EVP, Chief BUSINESS Off | S - Sale | $18.60 | -293 | 65.1K | -0.4% | -$5,450 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | S | D | 293 | $18.60 | 65,128 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $18.0525 to $18.61. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |